Golden ticket
“Golden Ticket” award for HEPHAISTOS from Amgen France and BioLabs Hôtel-Dieu
décembre 10, 2024

HEPHAISTOS-Pharma has the honor to be a winner of a Golden Ticket from Amgen France x BioLabs Hôtel-Dieu in Paris.

We have won one year of free residency at BioLabs Hôtel-Dieu and personalized mentorship from Amgen experts to accelerate the development of our innovative project and create synergies.

We would like to thank the jury members for their time, expertise and feedback. Their contributions are very useful for us to understand the pharmaceutical needs and to define the clinical strategy:

Nathalie Varoqueaux MD PhD, Executive Medical Director, Amgen
Marie MORICE-MORAND, Associate Director of Innovation & Digital, Amgen
Mads Nørregaard-Madsen, Scientific Director, Amgen R&D Copenhagen
Martha S. Head, Executive Director, Computational & Data Sciences, Amgen
Matthias Klinger, Director Research, Amgen Research Gmbh, Germany
Margalit Haber, Ph.D., Business Development Manager, R&D Transformation, Strategy & Opera-tions, Precision Medicine, Amgen
Gilles Gnacadja, PhD, Executive Director Data Sciences & Engineering, Technology Innovation Lab, Amgen
Matthew Foster, DBA, Executive Director Technology Strategy & Innovation, Technology Innovation Lab, Amgen
Saad Shah, Director Technology Strategy & Innovation, Digital & AI solutions, Technology Innovation Lab, Amgen
Dihya Benhamouche, Innovation Project Manager, Amgen
Special thanks to the BioLabs France Team for welcoming us and organizing the event Christophe Tallec and Johanna Michielin.